Hainan Shuangcheng Pharmaceuticals Co Ltd
SZSE:002693
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hainan Shuangcheng Pharmaceuticals Co Ltd
SZSE:002693
|
CN |
|
Hangzhou DPtech Technologies Co Ltd
SZSE:300768
|
CN |
|
Gujarat Alkalies And Chemicals Ltd
NSE:GUJALKALI
|
IN |
|
P
|
Pricer AB
STO:PRIC B
|
SE |
|
Shivam Autotech Ltd
NSE:SHIVAMAUTO
|
IN |
|
S
|
STMicroelectronics NV
XETRA:SGM
|
CH |
|
A
|
Adventa Bhd
KLSE:ADVENTA
|
MY |
|
Shenzhen Sunshine Laser & Electronics Technology Co Ltd
SZSE:300227
|
CN |
|
H
|
Halmont Properties Corp
XTSX:HMT
|
CA |
|
Volvo Car AB
STO:VOLCAR B
|
SE |
|
C
|
Chagee Holdings Ltd
NASDAQ:CHA
|
CN |
|
Energean PLC
LSE:ENOG
|
UK |
Bankruptcy Probability
Hainan Shuangcheng Pharmaceuticals Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hainan Shuangcheng Pharmaceuticals Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Hainan Shuangcheng Pharmaceuticals Co Ltd
SZSE:002693
|
3.3B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hainan Shuangcheng Pharmaceuticals Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hainan Shuangcheng Pharmaceuticals Co Ltd has total debt of 176.5m CNY. This includes both short-term (0 CNY) and long-term (176.5m CNY) debt.
You can find a full breakdown on its Balance Sheet.
